INDIVIOR UK LIMITED
Get an alert when INDIVIOR UK LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2026-07-02 (in 2mo)
Last made up 2025-06-18
Watchouts
Watchouts
Facts from the Companies House register and the latest accounts — not a rating
-
6 officer resignations in last 12 months
Multiple officers have left the board recently — see the People section for who.
Name history
Renamed 1 time since incorporation
- INDIVIOR UK LIMITED 2015-07-01 → present
- RB PHARMACEUTICALS LIMITED 2010-03-09 → 2015-07-01
Accounts
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- PricewaterhouseCoopers LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“These financial statements are prepared using the going concern basis of accounting. The Company's business activities, together with the factors likely to affect its future development and position, are set out in the Business Review section of the Strategic Report on page 2. The Company has net assets of $416,237k (2023: $327,755k). The Directors intend to continue the business operations in the foreseeable future.”
Group structure
- INDIVIOR UK LIMITED · parent
- Indivior Canada Ltd 100%
- Indivior Deutschland GmbH 100%
- Indivior España S.L.U. 100%
- Indivior EU Limited 100%
- Indivior Europe Limited 100%
- Indivior France SAS 100%
- Indivior Israel Ltd 100%
- Indivior Italia S.r.l. 100%
- Indivior Nordics ApS 100%
- Opiant Pharmaceuticals UK Limited 100%
- Indivior Schweiz AG 100%
Significant events
- “Effective 1 January 2024, the functional currency of Indivior UK Limited changed from pound sterling to U.S. dollar (USD).”
- “In June 2024, development of the remaining Opiant UK pipeline project addressing cannabis-use disorder via nasal inhaler was discontinued.”
- “On 9 July 2024, the Group announced the discontinuation of marketing and promotion for PERSERIS.”
- “On 4 September 2024, Aelis Farma announced that its clinical Phase 2B study with AEF0117 in participants with cannabis use disorder did not demonstrate the anticipated results.”
- “During the first quarter of 2025, the Group identified an error in the methodology used to accrue for Indivior's share of the annual U.S. fee imposed on drug manufacturers ... resulting in Indivior UK Limited being overcharged by $9,500k relating to prior years.”
- “In August 2025, the Group announced actions related to an initiative intended to maximise the potential of Indivior PLC's business...”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
3 active · 26 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| GIVENS, Alice Grace | Secretary | 2025-10-29 | — | — |
| CAIRNS, Graham | Director | 2023-11-01 | Nov 1970 | British |
| RUPANI, Bansari | Director | 2021-12-31 | Oct 1966 | British |
Show 26 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| DATHI, Cassie | Secretary | 2025-05-08 | 2025-10-29 |
| EMETULU, Lola Oloyade | Secretary | 2014-04-24 | 2015-06-15 |
| HUDSON, Kathryn Barbara | Secretary | 2015-06-15 | 2025-05-08 |
| RICHARDSON, Elizabeth Anne | Secretary | 2010-03-09 | 2014-04-24 |
| AMER, Bassel Antoine | Director | 2023-05-23 | 2023-10-04 |
| ARMSTRONG, David Frank | Director | 2010-03-09 | 2013-03-31 |
| BEARD, Katherine Julie | Director | 2018-11-19 | 2019-08-23 |
| BOJKOVSKY, Jozef | Director | 2015-02-19 | 2017-12-31 |
| CROSSLEY, Mark Wesley | Director | 2012-03-08 | 2015-02-19 |
| D'ANGELO, Massimo | Director | 2018-06-01 | 2024-12-31 |
| DAY, Colin Richard | Director | 2010-03-09 | 2011-02-08 |
| DOHERTY, Mary Elizabeth | Director | 2011-02-08 | 2013-02-12 |
| FOUCHE, Nicolas Pierre Jean Marie, Mr. | Director | 2024-12-31 | 2025-12-17 |
| GAWMAN, Andrew James | Director | 2011-02-08 | 2018-11-07 |
| GIBSON, Martyn George Alexander | Director | 2011-02-08 | 2012-03-08 |
| JAMESON, Richard Major | Director | 2013-03-01 | 2015-12-14 |
| PICARD, Gilles | Director | 2016-05-01 | 2023-05-02 |
| RIMIKIS, Michael | Director | 2015-02-19 | 2018-06-01 |
| ROBSON, James Richard | Director | 2010-03-09 | 2011-02-11 |
| SEHGAL, Sunil | Director | 2011-02-08 | 2014-12-19 |
| SHANK, Ms Amei W | Director | 2015-02-19 | 2019-12-31 |
| SHEPPARD, Abigail Christine | Director | 2021-12-31 | 2025-12-15 |
| SIMKIN, Richard | Director | 2015-02-19 | 2025-05-09 |
| STIER, Frank | Director | 2015-12-14 | 2020-04-01 |
| WEIS, Thomas | Director | 2018-11-07 | 2021-12-31 |
| WEST, Hillel Philip | Director | 2020-04-01 | 2025-12-15 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Rbp Global Holdings Limited | Corporate entity | Shares 75–100% | 2016-04-06 | Active |
Filing timeline
Last 20 of 161 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-03-31 | MR04 | mortgage | Mortgage satisfy charge full | |
| 2026-03-31 | MR04 | mortgage | Mortgage satisfy charge full | |
| 2026-03-31 | MR04 | mortgage | Mortgage satisfy charge full | |
| 2026-03-31 | MR04 | mortgage | Mortgage satisfy charge full | |
| 2026-03-31 | MR04 | mortgage | Mortgage satisfy charge full | |
| 2026-01-29 | PSC05 | persons-with-significant-control | Change to a person with significant control | |
| 2025-12-18 | TM01 | officers | Termination director company with name termination date | |
| 2025-12-15 | TM01 | officers | Termination director company with name termination date | |
| 2025-12-15 | TM01 | officers | Termination director company with name termination date | |
| 2025-10-29 | AP03 | officers | Appoint person secretary company with name date | |
| 2025-10-29 | TM02 | officers | Termination secretary company with name termination date | |
| 2025-10-22 | MR04 | mortgage | Mortgage satisfy charge full | |
| 2025-09-16 | AA | accounts | Accounts with accounts type full | |
| 2025-06-18 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-05-21 | AP03 | officers | Appoint person secretary company with name date | |
| 2025-05-21 | TM02 | officers | Termination secretary company with name termination date | |
| 2025-05-09 | TM01 | officers | Termination director company with name termination date | |
| 2025-02-20 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2025-01-07 | TM01 | officers | Termination director company with name termination date | |
| 2025-01-07 | AP01 | officers | Appoint person director company with name date |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 17
- Capital events
- 0
- Officers appointed
- 1
- Officers resigned
- 6
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
Latest filed period vs the prior one